File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/nep.13741
- Scopus: eid_2-s2.0-85087559030
- PMID: 32524684
- WOS: WOS:000545987900001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advances
Title | Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advances |
---|---|
Authors | |
Keywords | chronic kidney disease hepatitis B herpes zoster influenza invasive pneumococcal disease |
Issue Date | 2020 |
Publisher | Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1797 |
Citation | Nephrology, 2020, Epub 2020-06-10, p. article no. e13741 How to Cite? |
Abstract | Hepatitis B virus (HBV), influenza, pneumococcus and herpes zoster are important infections which could result in significant morbidity and mortality in patients with chronic kidney disease (CKD). While seroconversion rates after vaccination are often lower in CKD patients compared with healthy adults due to impaired innate and adaptive immunity, vaccinations for HBV, influenza, pneumococcus and herpes zoster are generally effective in reducing the transmission and/or severity of these infections. Practical issues that have an impact on the efficacy of vaccination in the CKD population include the timing, dose, schedule of vaccination, the route of administration, and adjuncts applied at time of vaccination. This review discusses the vaccination regimens and the efficacy of HBV, influenza, pneumococcus and zoster vaccines in CKD patients, and highlights recent advances in enhancing vaccine seroconversion rates. |
Persistent Identifier | http://hdl.handle.net/10722/287152 |
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 0.641 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ma, BM | - |
dc.contributor.author | Yap, DYH | - |
dc.contributor.author | Yip, TPS | - |
dc.contributor.author | Hung, IFN | - |
dc.contributor.author | Tang, SCW | - |
dc.contributor.author | Chan, TM | - |
dc.date.accessioned | 2020-09-22T02:56:34Z | - |
dc.date.available | 2020-09-22T02:56:34Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Nephrology, 2020, Epub 2020-06-10, p. article no. e13741 | - |
dc.identifier.issn | 1320-5358 | - |
dc.identifier.uri | http://hdl.handle.net/10722/287152 | - |
dc.description.abstract | Hepatitis B virus (HBV), influenza, pneumococcus and herpes zoster are important infections which could result in significant morbidity and mortality in patients with chronic kidney disease (CKD). While seroconversion rates after vaccination are often lower in CKD patients compared with healthy adults due to impaired innate and adaptive immunity, vaccinations for HBV, influenza, pneumococcus and herpes zoster are generally effective in reducing the transmission and/or severity of these infections. Practical issues that have an impact on the efficacy of vaccination in the CKD population include the timing, dose, schedule of vaccination, the route of administration, and adjuncts applied at time of vaccination. This review discusses the vaccination regimens and the efficacy of HBV, influenza, pneumococcus and zoster vaccines in CKD patients, and highlights recent advances in enhancing vaccine seroconversion rates. | - |
dc.language | eng | - |
dc.publisher | Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1797 | - |
dc.relation.ispartof | Nephrology | - |
dc.rights | Preprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Postprint This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. | - |
dc.subject | chronic kidney disease | - |
dc.subject | hepatitis B | - |
dc.subject | herpes zoster | - |
dc.subject | influenza | - |
dc.subject | invasive pneumococcal disease | - |
dc.title | Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advances | - |
dc.type | Article | - |
dc.identifier.email | Yap, DYH: desmondy@hku.hk | - |
dc.identifier.email | Yip, TPS: tpsyip@hku.hk | - |
dc.identifier.email | Hung, IFN: ivanhung@hkucc.hku.hk | - |
dc.identifier.email | Tang, SCW: scwtang@hku.hk | - |
dc.identifier.email | Chan, TM: dtmchan@hkucc.hku.hk | - |
dc.identifier.authority | Yap, DYH=rp01607 | - |
dc.identifier.authority | Hung, IFN=rp00508 | - |
dc.identifier.authority | Tang, SCW=rp00480 | - |
dc.identifier.authority | Chan, TM=rp00394 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/nep.13741 | - |
dc.identifier.pmid | 32524684 | - |
dc.identifier.scopus | eid_2-s2.0-85087559030 | - |
dc.identifier.hkuros | 314269 | - |
dc.identifier.volume | Epub 2020-06-10 | - |
dc.identifier.spage | article no. e13741 | - |
dc.identifier.epage | article no. e13741 | - |
dc.identifier.isi | WOS:000545987900001 | - |
dc.publisher.place | Australia | - |
dc.identifier.issnl | 1320-5358 | - |